Novartis’s Fiona Marshall Says RLT Can Treat Nearly Every Tumor as Pipeline Tops 20 Candidates — BigGo Finance
A Platform Bet on Radiation The most consequential idea in Fiona Marshall’s vision for Novartis research is also…
Novartis CEO shrugs off oral PCSK9 threat amid Q2 growth
Novartis’ CEO remains unfazed by the threat of a newly approved oral PCSK9 inhibitor in Merck & Co.’s…